The Taibo® Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.
MoreAulimodi raw materials and tablets received clinical approval from the NMPA on October 18, 2016.
MoreFlumarin® (flomoxef sodium for injection), the original product of Shionogi in Japan, exclusively distributed by us, and is currently a medical insurance drug in Hunan and Heilongjiang provinces, specifically, in provincial medical insurance class B.
MoreAobo Ping® (rabeprazole sodium for injection), the first generic by C&O, is currently a medical insurance drug in Jiangsu, Shandong, Henan, Hebei, Sichuan, Hunan, Heilongjiang, Yunnan, Guangxi, Guizhou, Ningxia and Tibet, specifically, in provincial
MoreShenzhen Liancheng Medicine Company Limited is the distribution center of C&O.
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account 
Mobile page